The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 501–600 of 999
P-407-induced Mouse Model of Dose-controlled Hyperlipidemia and Atherosclerosis: 25 Years Later
Johnston, T. P., Короленко, Т. А., & Sahebkar, A. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000522 · Cited by 42
Blum, A., Pastukh, N., Socea, D., & Jabaly, H. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.014 · Cited by 42
Sakaguchi, C., Nagata, Y., Kikuchi, A., Takeshige, Y., & Minami, N. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab014 · Cited by 42
Ribau, J. C. O., Hadcock, S. J., Teoh, K., Dereske, M., & Richardson, M. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5682 · Cited by 42
The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study
Haider, A. W., Larson, M. G., O’Donnell, C. J., Evans, J. C., Wilson, P. W. F., & Levy, D. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00027-3 · Cited by 41
Inflammation, Cell Adhesion Molecules, and Stroke: Tools in Pathophysiology and Epidemiology?
Blann, A. D., Ridker, P. M., & Lip, G. Y. H. (2002) · Stroke · doi:10.1161/01.str.0000029008.00497.d3 · Cited by 42
Tousoulis, D., Antoniades, C. A., Bosinakou, E., Kotsopoulou, M., Tsoufis, C., Marinou, K., Charakida, M., Stefanadi, E., Vavuranakis, M., Latsios, G., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.011 · Cited by 41
“Acute phase proteins such as CRP are involved in the prognosis of coronary artery disease [11,12].”
BackgroundToxicological effect of TiO2 nanoparticle-induced myocarditis in mice
Hong, F., Wang, L., Yu, X., Zhou, Y., Hong, J., & Sheng, L. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-1029-6 · Cited by 41
“Inflammatory cytokines, including IL-1β, TNF-α, and CRP, have been suggested to induce the expression of cellular adhesion molecules, which promote adhesion of leukocytes to the vascular endothelium [68, 69].”
BackgroundAmran, A. A., Zakaria, Z., Othman, F. B., Das, S., Al‐Mekhlafi, H. M., & Nordin, N. A. M. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-2 · Cited by 41
Tousoulis, D., Homaei, H., Ahmed, N., Asimakopoulos, G., Zouridakis, E., Toutouzas, P. C., & Davies, G. J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112683 · Cited by 41
Kawamura, T., Umemura, T., Kanai, A., Nagashima, M., Nakamura, N., Uno, T., Nakayama, M., Sano, T., Hamada, Y., Nakamura, J., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.007 · Cited by 41
Direct vascular effects of estrogens and selective estrogen receptor modulators
Simoncini, T., & Genazzani, A. R. (2000) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200006000-00004 · Cited by 41
Oger, E., Alhenc‐Gelas, M., Plu‐Bureau, G., Mennen, L. I., Cambillau, M., Guize, L., Pujol, Y., & Scarabin, P. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(00)00382-0 · Cited by 41
Obesity Genotype Score and Cardiovascular Risk in Women With Type 2 Diabetes Mellitus
He, M., Cornelis, M. C., Franks, P. W., Zhang, C., Hu, F. B., & Qi, L. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196196 · Cited by 40
Sun, S., Pan, Q. Z., Hui, X., Zhang, B., Wu, H., Li, H., Xu, W., Zhang, Q., Li, J. Y., Deng, X., et al. (2008) · Poultry Science · doi:10.3382/ps.2007-00202 · Cited by 40
“, 1998), and soluble cell adhesion molecules, such as intercellular adhesion molecule, vascular cell adhesion molecule, and sE-selectin (Hackman et al., 1996; Ridker et al., 1998).”
BackgroundFarzan, S. F., Howe, C. G., Zens, M. S., Palys, T. J., Channon, J. Y., Li, Z., Chen, Y., & Karagas, M. R. (2017) · Environmental Health Perspectives · doi:10.1289/ehp2062 · Cited by 42
“…reported a positive association between these markers and an increased risk of CVD morbidity and mortality (Hwang et al. 1997; Ridker et al. 1998; Rohde et al. 1998), a more recent study reported an inverse association between prospectively measured VCAM-1 levels and CVD risk, suggesting that…”
ResultYu, H., Sheu, W. H., Song, Y., Liu, H., Lee, W. K., & Chen, Y.-T. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01144.x · Cited by 40
Vince, R. V., Sandström, M., Taylor, L. K., McNaughton, L. R., Laden, G., & Madden, L. A. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-01-0030 · Cited by 40
Kozera, Ł., Andrews, J., & Morgan, A. W. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker232 · Cited by 40
Chapter 3 Effect of Hormone Replacement Therapy on Inflammatory Biomarkers
Γεωργιάδου, Π., & Sbarouni, E. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)47003-3 · Cited by 38
Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury
Mendez, M. P., Morris, S. B., Wilcoxen, S. E., Greeson, E., Moore, B. B., & Paine, R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2005 · Cited by 40
Turesson, C. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.12.1346 · Cited by 40
Blum, A., Schenke, W. H., Hathaway, L., Mincemoyer, R., Csákó, G., Waclawiw, M. A., & Cannon, R. O. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01116-4 · Cited by 40
van Ree, R. M., Oterdoom, L. H., de Vries, A. P. J., van der Heide, J. J. H., van Son, W. J., Navis, G., Gans, R. O. B., & Bakker, S. J. L. (2008) · Transplantation · doi:10.1097/tp.0b013e3181903d25 · Cited by 39
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease
Chen, J., Bundy, J. D., Hamm, L. L., Hsu, C., Lash, J. P., Miller, E. R., Thomas, G., Cohen, D. L., Weir, M. R., Raj, D. S., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12358 · Cited by 39
Cirillo, P. L., Rosa, S. D., Pacileo, M., Gargiulo, A., Angri, V., Fiorentino, I., Prevete, N., Petrillo, G., Palma, R. D., Leonardi, A., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02923.x · Cited by 39
van Mieghem, C. A. G., Bruining, N., Schaar, J. A., McFadden, E. P., Mollet, N. R., Cademartiri, F., Mastik, F., Ligthart, J. M. R., Rodríguez-Granillo, G. A., Valgimigli, M., et al. (2005) · International journal of cardiac imaging · doi:10.1007/s10554-004-7986-y · Cited by 39
Park, S.-J., Do, J.-Y., Kim, Y. H., Lee, H. Y., Kim, B. S., Shin, S., Kim, H., Chang, Y., Yang, J.-O., Chung, H. C., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr451 · Cited by 39
“Other evidence showed that clinically overt vascular events are preceded by endothelial dysfunction and increase in circulating markers of endothelial activation, including vascular cellular adhesion molecule (VCAM)-1 and intercellular adhesion molecule (ICAM)-1 [6, 7].”
BackgroundThe assessment of endothelial function in humans
Farouque, H. M. O., & Meredith, I. T. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200109000-00003 · Cited by 39
Ponthieux, A., Lambert, D., Herbeth, B., Droesch, S., Pfister, M., & Visvikis‐Siest, S. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201033 · Cited by 39
van Tits, L. J. H., Waart, F. G. D., Hak-Lemmers, H. L. M., van Heijst, P. J., Graaf, J. D., Demacker, P. N. M., & Stalenhoef, A. F. H. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00519-6 · Cited by 38
Fielding, R. A., Atkinson, E. J., Aversa, Z., White, T. A., Heeren, A. A., Mielke, M. M., Cummings, S. R., Pahor, M., Leeuwenburgh, C., & LeBrasseur, N. K. (2024) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glad257 · Cited by 38
The Association of Social Status and Blood Pressure With Markers of Vascular Inflammation
Hong, S., Nelesen, R. A., Krohn, P. L., Mills, P. J., & Dimsdale, J. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000227684.81684.07 · Cited by 38
“6, as compared with individuals in the lower quartiles (33).”
BackgroundPak, V. M., Keenan, B. T., Jackson, N., Grandner, M. A., Maislin, G., Teff, K. L., Schwab, R. J., Arnardóttir, E. S., Júlíusson, S., Benediktsdottir, B., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.123 · Cited by 38
“Previous studies typically assess CAM levels at baseline and examine differences between those who do and do not develop cardiovascular events over several years of follow-up(30, 31, 35–37).”
Lee, W., Chen, L., Liang, C., Peng, L., Chiou, S.-T., & Chou, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157877 · Cited by 38
“The elevation in the sICAM-1 levels in frail individuals in this study was not as marked as for levels observed in tumors, such as in lung cancer (>414 ng/ml) [26] and breast cancer, as well as with HIV infection (1,086 ng/ ml) [27]; however, they were similar to values for the prediction of future myocardial infracti…”
ResultMusso, G., Saba, F., Cassader, M., Paschetta, E., Michieli, F. D., Pinach, S., Framarin, L., Berrutti, M., Leone, N., Parente, R., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000154 · Cited by 38
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies
Kabrhel, C., Varraso, R., Kraft, P. L., Rimm, E. B., Goldhaber, S. Z., Camargo, C. A., Fuchs, C. S., & Wolpin, B. M. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0312 · Cited by 40
“The extracellular domains of E-selectin, P-selectin and ICAM-1 are shed into the circulation (39), where their levels have been linked to incident cardiovascular disease and diabetes mellitus (40, 41).”
BackgroundNg, M. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.02.108 · Cited by 37
Preis, S. R., Ridker, P. M., Zee, R. Y. L., & Cook, N. R. (2005) · Human Genetics · doi:10.1007/s00439-005-0052-6 · Cited by 38
“Intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 are involved in the adhesion and transmigration of leukocytes through the vascular endothelium and have been found to be expressed in atherosclerotic plaques (Libby et al. 2002; Ridker et al. 1998).”
Markers of preclinical atherosclerosis and their clinical relevance
Poredoš, P., & Jezovnik, M. K. (2015) · VASA · doi:10.1024/0301-1526/a000439 · Cited by 37
“Furthermore, ICAM-1 levels may predict cardiovascular event rates in apparently healthy men [49].”
BackgroundHigher carotid‐radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes
McEleavy, O. D., McCallum, R. W., Petrie, J. R., SMALL, M. P., Connell, J. M. C., Sattar, N. A., & Cleland, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01127.x · Cited by 38
Capra, F., Maria, E. D., Lunardi, C., Marchiori, L., Mezzelani, P., Beri, R., & Gabrielli, G. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315265 · Cited by 38
“These results were not influenced by smoking, because the percentage of smokers was the same in both groups [30].”
ResultDenniss, S. G. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.213 · Cited by 37
“Our female subjects were recruited into the study after we studied the men and compared their blood biochemical responses to the HFm and the LFm (see Blood processing and biochemical analyses, Methods below), and since the HFm did not provoke responses in blood antioxidants or biomarkers of…”
Wu, F., Jasmine, F., Kibriya, M. G., Liu, M., Cheng, X., Parvez, F., Islam, T., Ahmed, A., Rakibuz‐Zaman, M., Jiang, J., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1307883 · Cited by 37
Cardiovascular disease in patients with autoinflammatory syndromes
Hintenberger, R., Falkinger, A., Danninger, K., & Pieringer, H. (2017) · Rheumatology International · doi:10.1007/s00296-017-3854-7 · Cited by 37
Oarada, M., Tsuzuki, T., Gonoi, T., Igarashi, M., Kamei, K., Nikawa, T., Hirasaka, K., Ogawa, T., Miyazawa, T., Nakagawa, K., et al. (2007) · Nutrition · doi:10.1016/j.nut.2007.10.006 · Cited by 37
Rao, M., Jaber, B. L., & Balakrishnan, V. S. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00138.x · Cited by 37
Speidl, W. S., Zeiner, A., Nikfardjam, M., Geppert, A., Jordanova, N., Niessner, A., Zorn, G., Maurer, G., Schreiber, W., Wojta, J., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.052 · Cited by 37
Blann, A. D., & Lip, G. Y. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1745 · Cited by 37
Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients
Lee, W., Lee, Y., Kim, J.-R., Chu, J.-A., Lee, S.-Y., Jung, J.-O., Kim, J.-S., Kim, S., Seo, J., Rhee, S. S., et al. (1999) · Experimental & Molecular Medicine · doi:10.1038/emm.1999.26 · Cited by 37
“The plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1) were also shown to have a significant association with the risk of future myocardial infarction ( Ridker et al., 1998 ).”
BackgroundPapasavvas, E., Azzoni, L., Pistilli, M., Hancock, A. S., Reynolds, G., Gallo, C., Ondercin, J., Kostman, J. R., Mounzer, K., Shull, J., et al. (2008) · AIDS · doi:10.1097/qad.0b013e328303be2a · Cited by 36
“However, their reciprocal pathogenic role in cardiovascular disease remains controversial based on several studies showing significant associations between atherosclerosis and either sICAM-1 [32–36] or sVCAM-1 [22,37,38] or both [22,39,40].”
BackgroundSerum Interleukin-15 Concentration in Patients With Essential Hypertension
Kaibe, M., Ohishi, M., Ito, N., Ma, Y., TAKAGI, T., TERAI, M., Tatara, Y., Komai, N., Rakugi, H., & Ogihara, T. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.02.014 · Cited by 36
Detecting Vulnerable Plaque Using Peripheral Blood:
Schwartz, R. S., Bayés‐Genís, A., Lesser, J. R., Sangiorgi, G., Henry, T. D., & Conover, C. A. (2003) · Journal of Interventional Cardiology · doi:10.1034/j.1600-0854.2003.8025.x · Cited by 36
The effects of green tea ingestion over four weeks on atherosclerotic markers
Sung, H., Min, W.-K., Lee, W., Chun, S., Park, H., Lee, Y.-W., Jang, S., & Lee, D.-H. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563054255597 · Cited by 35
Relationships between Vitamin D Status and Cardio-Metabolic Risk Factors in Young European Adults
Muldowney, S., Lucey, A. J., Paschos, G. K., Martínez, J. A., Bandarra, N. M., Þórsdóttir, I., Cashman, K. D., & Kiely, M. E. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000324600 · Cited by 35
“and high concentrations of ICAM-1 in apparently healthy adults predict an increased risk of future cardiovascular events [”
BackgroundLow-carbohydrate diets, obesity, and metabolic risk factors for cardiovascular disease
Samaha, F. F., Foster, G. D., & Makris, A. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0059-7 · Cited by 35
“Prior studies have demonstrated that levels of soluble intercellular adhesion molecules [ 35 ,36], soluble vascular cell adhesion molecule, soluble E selectin [36], and C-reactive protein (CRP) [37] predict cardiovascular events.”
BackgroundZaid, M. I. A., Gathirua‐Mwangi, W. G., Fung, C., Monahan, P. O., El-Charif, O., Williams, A. M., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., Beard, C. J., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.7046 · Cited by 35
Tonstad, S., Sundfør, T. M., & Seljeflot, I. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.047 · Cited by 35
Jilma, B., Joukhadar, C., Derhaschnig, U., Rassoul, F., Richter, V., Wolzt, M., Dorner, G. T., Petternel, V., & Wagner, O. F. (2003) · Clinical Science · doi:10.1042/cs20020168 · Cited by 35
Endothelial function and its assessment
Felmeden, D. C., & Lip, G. Y. H. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1319 · Cited by 35
“Elevated plasma levels of several markers of the inflammatory cascade can predict future risk of plaque rupture [24].”
BackgroundKwok, T. C. Y., Leung, P., Lam, C. W. K., Ho, S. C., Wong, C. K., Cheng, K. F., & Chook, P. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.03.010 · Cited by 35
Marschang, P., Friedrich, G. J., Ditlbacher, H., Stoeger, A., Nedden, D. Z., Kirchmair, R., Dienstl, A., Pachinger, O. M., & Patsch, J. R. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.042 · Cited by 35
“have provided strong evidence for the association between elevated levels of soluble ICAM-1 and future coronary events [55].”
BackgroundRegister, T. C., Burdon, K. P., Lenchik, L., Bowden, D. W., Hawkins, G. A., Nicklas, B. J., Lohman, K., Hsu, F., Langefeld, C. D., & Carr, J. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036806 · Cited by 35
The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I
Armani, A. M., & Becker, R. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.031 · Cited by 35
Manning, P. J., Sutherland, W. H. F., Allum, A. R., de Jong, S. A., & Jones, S. D. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00808.x · Cited by 35
The Effects of Raloxifene and Simvastatin on Plasma Lipids and Endothelium
Sbarouni, E., Flevari, P., Κroupis, C., Kyriakides, Z. S., Koniavitou, K., & Kremastinos, D. T. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1027391405600 · Cited by 35
“[ 22 ]. Estrogen therapy reduces the levels of soluble adhesion molecules in both healthy [23] and coronary postmenopausal women [24‐26] whereas statins do not [27,28].”
BackgroundSbarouni, E. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1988 · Cited by 35
“Moreover, those with the highest levels of sICAM-1 are at the highest risk([30]); this observation raises the possibility that antiadhesion therapies may play a role in the prevention and treatment of coronary disease([31]).”
BackgroundKristoffersen, U. S., Kofoed, K. F., Kronborg, G., Benfield, T., Kjær, A., & Lebech, A. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00733.x · Cited by 34
Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney Disease
Stinghen, A. E. M., Bucharles, S. G. E., RIELLA, M. C., & Pecoits‐Filho, R. (2010) · Blood Purification · doi:10.1159/000245636 · Cited by 35
Cottone, S., Palermo, A., Vaccaro, F., Mulè, G., Guarneri, M., Arsena, R., Vadalà, A., & Cerasola, G. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00405.x · Cited by 34
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
Babiker, A., Hassan, M. S., Muhammed, S., Taylor, G. H., Poonia, B., Shah, A. S. V., & Bagchi, S. (2019) · Clinical Cardiology · doi:10.1002/clc.23299 · Cited by 33
Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events
Binkley, P. F., Cooke, G. E., Lesinski, A., Taylor, M. B., Chen, M., Laskowski, B. F., Waldman, W. J., Ariza, M. E., Williams, M. V., Knight, D. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054008 · Cited by 36
Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression
Kondo, K., Kitagawa, K., Nagai, Y., Yamagami, H., Hashimoto, H., Hougaku, H., & Hori, M. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.018 · Cited by 34
Endothelial function and myocardial infarction
Bhagat, K. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00138-2 · Cited by 34
Takeuchi, N., Kawamura, T., Kanai, A., Nakamura, N., Uno, T., Hara, T., Sano, T., Sakamoto, N., Hamada, Y., Nakamura, J., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00631.x · Cited by 34
Serum levels of selected adhesion molecules in patients with coronary artery disease
Mizia‐Stec, K., Zahorska‐Markiewicz, B., Mandecki, T., Janowska, J., Szulc, A., & Jastrzebska-Maj, E. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00032-3 · Cited by 34
Blanco‐Colio, L. M., Martı́n-Ventura, J. L., Sol, J. M., Díaz, C., Hernández, G., & Egido, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.046 · Cited by 34
Rahman, T. H. A., Hamzan, N. S., Mokhsin, A., Rahmat, R., Ibrahim, Z. O., Razali, R., Thevarajah, M., & Nawawi, H. M. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0470-1 · Cited by 33
Hegazy, G. A., Awan, Z. A., Hashem, E., Alama, N., & Abunaji, A. B. (2019) · Journal of International Medical Research · doi:10.1177/0300060519893858 · Cited by 33
“In prospective studies, however, elevated sVCAM-1 levels were not related to cardiovascular risk events.19,28 This finding is in contrast to the results of other studies of CAMs, such as ICAM-1 and E-selectin.19,20 These differences may be because of the small sample sizes or the absence of information on complication…”
BackgroundResultInfluentialCsordás, A., Wick, G., Laufer, G., & Bernhard, D. (2008) · Biomarker Insights · doi:10.4137/bmi.s480 · Cited by 33
“…for CVD Biomarker Insights 2008:3 there is a large body of evidence pointing to elevated levels of various markers of oxidative stress in smokers, prospective studies on the predictive value of these markers for clinical cardiovascular endpoints are sparse and have yielded inconsistent results.”
Antiinflammatory Effects of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure
THEODORAKIS, G. N., Flevari, P., Κroupis, C., Adamopoulos, S. N., LIVANIS, E. G., Κωστοπούλου, Ά., Kolokathis, F., PARASKEVAIDIS, I. A., Leftheriotis, D. I., & Kremastinos, D. T. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00331.x · Cited by 33
Schrepfer, S., Deuse, T., Münzel, T. F., Schäfer, H., Braendle, W. L., & Reichenspurner, H. C. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000185941.63497.10 · Cited by 34
“A large clinical study showed that baseline levels of soluble ICAM-1 were higher among patients who had suffered myocardial infarction than among those who had not.(38) The Atherosclerosis Risk in Communities study revealed that the relative risk of coronary artery disease among women and men in the highest quartile o…”
BackgroundWang, Y., Wang, Z., Zhou, Y., Liu, L., Zhao, Y., Yao, C., Wang, L., & Qiao, Z. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.004 · Cited by 33
Albert, M. A., Rifai, N., & Ridker, P. M. (2001) · Vascular Medicine · doi:10.1177/1358836x0100600304 · Cited by 33
Trøseid, M., Lappegård, K., Mollnes, T., Arnesen, H., & Seljeflot, I. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013811 · Cited by 32
“Moreover, levels of circulating CAMs have been associated with cardiovascular morbidity and mortality [5,6].”
BackgroundThe importance of total cardiovascular risk assessment in clinical practice
Graham, I. M. (2006) · European Journal of General Practice · doi:10.1080/13814780600976282 · Cited by 32
“The role of newer risk factors, such as plasma levels of lipoprotein(a), homocysteine (43 45), coagulation factors (e.g. fibrinogen and plasminogen activator inhibitor) (46,47), circulating adhesion molecules (e.g. VCAM-1, ICAM-1) (48,49) as well as markers of inflammation (especially C-reactive protein, CRP) (50) and…”
BackgroundSarecka‐Hujar, B., Żak, I., & Krauze, J. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0022-0 · Cited by 32
“atheroclerosis [5–7] and myocardial infarction [8].”
What causes acute coronary syndromes? Applying Koch's postulates
Monaco, C. G., Mathur, A., & Martin, J. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.022 · Cited by 32
Importance of microembolization and inflammation in atherosclerotic heart disease
Yamada, D. M., & Topol, E. J. (2000) · American Heart Journal · doi:10.1067/mhj.2000.111611 · Cited by 32
Endothelial activation and response in patients with hand arm vibration syndrome
Kennedy, G., Khan, McLaren, & Belch, J. J. F. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00502.x · Cited by 32
Walker, G., Langheinrich, A. C., Dennhauser, E., Bohle, R. M., Dreyer, T., Kreuzer, J., Tillmanns, H., Braun-Dullaeus, R. C., & Haberbosch, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2673 · Cited by 32
Strahler, J., Rohleder, N., & Wolf, J. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.014 · Cited by 32
“Systemic inflammation has been identified as one of the major pathophysiological mechanisms underlying life-threatening human diseases such as coronary heart disease and stroke (e.g., Danesh et al., 2000; Hansson, 2005; Pradhan et al., 2001; Ridker et al., 1998).”
BackgroundThompson, J. E. S., Smith, W. T., Ware, L. J., Mels, C. M. C., van Rooyen, J. M., Huisman, H. W., Malan, L., Malan, N. T., Lammertyn, L., & Schutte, A. E. (2015) · Hypertension Research · doi:10.1038/hr.2015.123 · Cited by 31
Bagley, J., Yuan, J., Chandrakar, A., & Iacomini, J. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13351 · Cited by 32
Cellular adhesion molecules and blood pressure
Miller, M. A., Kerry, S., Cook, D. G., & Cappuccio, F. P. (2004) · Journal of Hypertension · doi:10.1097/00004872-200404000-00012 · Cited by 31
Soeki, T., Tamura, Y., Shinohara, H., Sakabe, K., Onose, Y., & Fukuda, N. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00564-8 · Cited by 31
Chemokine RANTES is increased at early stages of coronary artery disease.
Podolec, J., Kopeć, G., Niewiara, Ł., Komar, M., Guzik, B., Bartuś, K., Pająk, L. T., Guzik, T. J., Płazak, W., & Zmudka, K. F. (2016) · PubMed · Cited by 31
Bongard, V., Élias, A., Sollier, C. B. D., Ruidavets, J., Boccalon, H., Drouet, L. O., & Ferrières, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00071-0 · Cited by 31
Pischon, N., Hägewald, S., Kunze, M., Heng, N. H. M., Christan, C., Kleber, B., Müller, C., & Bernimoulin, J. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060286 · Cited by 31
Badı́a, E., Nicolas, J. M., Fernández‐Solà, J., Antúnez, E., Urbano-Márquez, A., Estruch, R., & Sacanella, E. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613153 · Cited by 31
“In addition, experimental studies have suggested that some adhesion molecules expressed on the surface of endothelium, monocytes and other cells, which mediate cell-to-cell and cell-to-matrix interactions, play an important role in atherosclerosis (5-8).”
BackgroundResultInfluential
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review